Affiliation:
1. Institute of Pharmaceutical Research, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
Abstract
According to traditional Chinese medicine, Scutellaria baicalensis Georgi possesses the therapeutic properties of heat-clearing, dampness-drying, diarrhea alleviation, and detoxification, making it a clinically used remedy for respiratory infections. The objective of this study was to investigate the changes in constituent content, pharmacodynamic effects, and material basis of Scutellaria baicalensis Georgi in the plasma of mice infected with respiratory syncytial virus (RSV). The results showed that a sensitive and efficient high-performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) method was established in this study. Multiple quantitative analyses of Baicalein, Apigenin-7-glucuronide, Baicalin, Oroxylin A 7-O-beta-d-glucuronide, Wogonoside, Norwogonin, Wogonin, Chrysin, and Oroxylin A in mouse plasma revealed a bimodal absorption phenomenon within the time frame of 0.167 h to 6 h post-administration, with the exception of chrysin. Following 6 h of administration, the concentrations of 9 components continued to decrease until they became undetectable. In comparison to the model group, all administered groups exhibited significant reductions in lung index and viral load, with their lung index repair rate and viral suppression rate aligning with the blood concentration-time curve. Finally, through the application of the gray correlation analysis method, we identified Baicalein, Baicalin, Oroxylin A 7-O-beta-d-glucuronide, Wogonoside, Norwogonin, and Wogonin as potential pharmacodynamic material bases of Scutellaria baicalensis Georgi against RSV infection.
Funder
Key Research and Development plan sub-topics of Shandong Province
Natural Science Foundation Innovation and Development Joint Fund Project of Shandong Province
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference35 articles.
1. Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient with Ribavirin;Mir;Cureus,2021
2. Bronchial Epithelial Cells Promote the Differentiation of Th2 Lymphocytes in Airway Microenvironment through Jagged/Notch-1 Signaling after RSV Infection;Qin;Int. Arch. Allergy Immunol.,2019
3. Respiratory Syncytial Virus: A Comprehensive Review of Transmission, Pathophysiology, and Manifestation;Kaler;Cureus,2023
4. Shtro, A.A., Petukhova, G.D., and Romanova, A.S. (2022). Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State. Molecules, 27.
5. Clinical Development of Respiratory Syncytial Virus Antivirals-What We Can Learn from Oseltamivir;Bont;Clin. Infect. Dis.,2020